Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone hydrochloride liposome injection plus cytarabine in acute myeloid leukemia
CTR20212668Phase 2Active
- Sponsor
- CSPC Zhongnuo Pharmaceutical
- Start
- Nov 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone, cytarabine in acute myeloid leukemia (AML), sponsored by CSPC Zhongnuo Pharmaceutical. Started Nov 2021; status: active.
02
Drugs
mitoxantronecytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20212668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212668.